↓ Skip to main content

Dove Medical Press

Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC)

Overview of attention for article published in Therapeutics and Clinical Risk Management, June 2008
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

facebook
1 Facebook page
wikipedia
1 Wikipedia page

Readers on

mendeley
25 Mendeley
Title
Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC)
Published in
Therapeutics and Clinical Risk Management, June 2008
DOI 10.2147/tcrm.s2248
Pubmed ID
Authors

Enriqueta Felip, Rafael Rosell

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Other 6 24%
Student > Master 3 12%
Student > Postgraduate 3 12%
Student > Bachelor 2 8%
Researcher 2 8%
Other 6 24%
Unknown 3 12%
Readers by discipline Count As %
Medicine and Dentistry 12 48%
Agricultural and Biological Sciences 4 16%
Biochemistry, Genetics and Molecular Biology 2 8%
Unspecified 1 4%
Psychology 1 4%
Other 1 4%
Unknown 4 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2014.
All research outputs
#8,262,981
of 25,377,790 outputs
Outputs from Therapeutics and Clinical Risk Management
#434
of 1,323 outputs
Outputs of similar age
#33,221
of 97,662 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#3
of 8 outputs
Altmetric has tracked 25,377,790 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 97,662 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.